COMMUNIQUÉS West-GlobeNewswire

JSC Olainfarm: the Council of the Company has been elected legally and works for the long-term interests of the company
13/09/2018
The new council of JSC Olainfarm has been elected legally, represents the interests of shareholders and works in the long-term interests of the company, implementing and developing the vision of development of Valērijs [...]
Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018"
13/09/2018
PRESS RELEASE Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "European Huntington's Disease Network (EHDN) plenary meeting 2018" Lund Sweden, [...]
HealthLynked Corp. Announces Partnership to Offer Discount Medical Supplies to its Members and Healthcare Providers
13/09/2018
NAPLES, Fla., Sept. 13, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced its partnership with MedOfficeDirect, LLC, an online retailer of discount medical supplies. MedOfficeDirect sells [...]
Solon Eiendom ASA – Primary insider notification
13/09/2018
(Oslo, Norway, September 12, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 10.000 shares in Solon Eiendom ASA at a price of NOK 29,0632. Following [...]
Shire plc : Rule 2.9 Announcement
13/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 September 2018 [...]
ERYTECH to Attend Upcoming Investor Conferences
13/09/2018
LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside [...]
ERYTECH participera à plusieurs conférences d'investisseurs
13/09/2018
LYON, France, 13 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans [...]
ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
13/09/2018
CryoSave has fully equipped this new safe and secure sample storage BioBank in its state-of-the-art central laboratory in Geneva, Switzerland especially designed for optimal cryopreservation of all biological samples [...]
Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx® in daily life for psoriasis patients
13/09/2018
Real-world evidence confirms Cosentyx ® efficacy and safety consistent with previously reported clinical studies [1]-[4] Novartis presents a large program of real-world evidence at the 27 th European Academy of [...]
Abeona Therapeutics annonce l'autorisation de commencer l'étude clinique de phase 1/2 sur la thérapie génique pour les patients atteints de MPS IIIB en Espagne
13/09/2018
Un essai clinique pour ABO-101 (AAV-NAGLU) marque le 2e programme MPS III en Europe La société prévoit de créer des sites cliniques supplémentaires dans certains pays européens, dont la France, l'Allemagne et le Royaume [...]
Galapagos raises $300 million gross proceeds in a U.S. public offering
13/09/2018
Mechelen, Belgium, 13 September 2018, 03.00 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the pricing of its U.S. public offering totaling $ 300 million gross proceeds of 2,575, [...]
Xenon Pharmaceuticals Announces Pricing of $63.0 Million Public Offering of Common Shares
13/09/2018
BURNABY, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced the pricing of its underwritten [...]
XBiotech annonce l’arrivée d’un éminent cardiologue de renommée mondiale, le Dr. Peter Libby qui rejoint son Comité scientifique consultatif
13/09/2018
AUSTIN, Texas, 13 sept. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a le plaisir d’annoncer la nomination au sein de son Comité scientifique consultatif de Peter Libby, MD. Le Dr. Libby travaillera avec [...]
Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders
13/09/2018
CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual and Special Meeting of Shareholders (the “Meeting”) in Calgary, Alberta. A [...]
Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders
13/09/2018
Archive of the Executive Presentation to be Posted to the Zenith Website CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual meeting of [...]
Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children and adolescents with MS
12/09/2018
Treatment with Gilenya (fingolimod) substantially reduced the debilitating impact of MS, with significant decreases in key measures of disease activity vs. interferon beta-1a MS severely affects the everyday lives of [...]
Galapagos announces launch of proposed public offering
12/09/2018
Mechelen, Belgium, 12 September 2018, 22.45 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that it intends to offer and sell, subject to market and other conditions, $300 million [...]
Foamix Announces Proposed Follow-on Offering of Ordinary Shares
12/09/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]
Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
12/09/2018
ALPHARETTA, Ga., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Pages